Author Archives: AgeCurve
Grandmothers, longevity, proximity; three cheers for Grandmothers! ‘Grandmother effect’ helps explain human longevity Two new studies, both published in Current Biology, strengthen this notion. An analysis of church birth and death records in Finland for individuals born between 1731 and 1890 showed that having a maternal grandmother between 50 and 75 years of age while […]
One of the best known hallmarks of aging is related to metabolic alterations. Metabolism covers diverse processes providing new building blocks and energy for the body via the digestion of food. We have finally added a Metabolism Super Story backed by several underlying Protein Stories! Our users can check their Metabolism results and personalised Aging Scores by […]
Sam Knight, a staff writer at The New Yorker wrote a wonderful piece on the rise of palaeoproteomics, and as a side effect he helped to advance the mainstream understanding on what high-throughput mass spec proteomics (AgeCurve’s main method) can deliver.
NHS prevention plan for explicitly longer and healthier lives: a historical first longevity initiative?
A BBC piece called NHS prevention plan aims to boost life expectancy tells us about a prevention plan that might be a historical first longevity initiative at such a governmental scale: In his speech later, Mr Hancock is expected to set out his aim for people to have five more years of healthy, independent life by […]
AgeCurve’s founder and director, Attila Csordas has been invited to give a talk and participate in a panel discussion at the inaugural Longevity World Forum on the 8th of November in Valencia, Spain. The talk is entitled ‘AgeCurve, proteomics and extending healthspan: from free solo to aided rock climbing’.
Study: Fisetin is a senotherapeutic that extends health and lifespan Publication status and journal: Open Access in EBioMedicine published by The Lancet. Motivation behind study: Some drugs have senolytic activities, clearing out senescent cells but they also have considerable toxicity. Earlier, quercetin a flavonoid, used as a cheap supplement, shown some senotherapeutic promise as well. The […]
The Journal of the American Medical Association (JAMA) is one of the top, most influential US medical journals. Now it’s featuring some aging and longevity related articles, out of which we recommend two.
Starting a new series on the blog, sharing 3 interesting links in the field of healthspan extension and aging in general. Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States. Emerging findings are revealing mechanisms by which sedentary overindulgent lifestyles accelerate brain aging, whereas lifestyles that include intermittent bioenergetic challenges (exercise, fasting, and intellectual […]
AgeCurve’s founder and director, Attila Csordas has been invited to give a talk at the Health Tech Technology Ventures Conference on the 20th of June. The event is organised by Cambridge University Technology & Enterprise Club (CUTEC). It’s the 15th annual TVC conference focusing on the future of health tech. It’s a special event for AgeCurve […]
AgeCurve’s founder and director, Attila Csordas has been invited to attend Founders Forum‘s HealthTech event on the 15th of June, near London, UK. The prestigious, invitation-only event is focusing this year on Oncology, Senescence and Illnesses of Ageing and brings together scientists and medical researchers, tech entrepreneurs, investors, policy makers and senior execs from leading pharmaceutical companies.